Larvol Delta - Servier-and-Black-Diamond-Therapeutics-Announce-Global-Licensing-Agreement-for-BDTX4933-A-Targeted-Oncology-Therapy

BDTX-4933 - Servier

https://www.globenewswire.com/news-release/2025/03/19/3045227/0/en/Servier-and-Black-Diamond-Therapeutics-Announce-Global-Licensing-Agreement-for-BDTX-4933-A-Targeted-Oncology-Therapy.html

Mar 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next